New Drug Application Submitted To FDA For Investigational Analgesic Tapentadol Immediate Release Tablets
Jan 29th 2008Drug InformationPain / Anesthetics
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for tapentadol hydrochloride immediate release (IR) tablets, an investigational oral analgesic for the relief of moderate to severe acute pain.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
